口腔癌治疗：对未参保和参保不足人群的政策影响 - Suppr

Suppr

超能文献

Oral cancer therapy: policy implications for the uninsured and underinsured populations.

作者信息

Faiman Beth

机构信息

Cleveland Clinic, Cleveland, Ohio.

出版信息

J Adv Pract Oncol. 2013 Sep;4(5):354-60. doi: 10.6004/jadpro.2013.4.5.7.

DOI:10.6004/jadpro.2013.4.5.7

PMID:25032014

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4093446/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb4a/4093446/babb0d577cbe/jadp-04-354-g01.jpg

相似文献

Oral cancer therapy: policy implications for the uninsured and underinsured populations.

J Adv Pract Oncol. 2013 Sep;4(5):354-60. doi: 10.6004/jadpro.2013.4.5.7.

Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women.

BMC Womens Health. 2018 Oct 3;18(1):162. doi: 10.1186/s12905-018-0656-3.

Antidepressant Target Dose Optimization and Control of Severe Asthma Exacerbations in Uninsured and Underinsured Patients with Anxiety and/or Depression.

Pharmacotherapy. 2020 Apr;40(4):320-330. doi: 10.1002/phar.2374. Epub 2020 Mar 10.

Cost-efficient treatment for uninsured or underinsured patients with hypertension, depression, diabetes mellitus, insomnia, and gastroesophageal reflux.

J Am Acad Nurse Pract. 2008 Mar;20(3):136-43. doi: 10.1111/j.1745-7599.2007.00302.x.

Insured but not protected: how many adults are underinsured?

Health Aff (Millwood). 2005 Jan-Jun;Suppl Web Exclusives:W5-289-W5-302. doi: 10.1377/hlthaff.w5.289.

Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review, Part 1.

Headache. 2018 Apr;58(4):506-511. doi: 10.1111/head.13286. Epub 2018 Mar 8.

Insurance Status Among Adults With Hypertension-The Impact of Underinsurance.

J Am Heart Assoc. 2016 Dec 21;5(12):e004313. doi: 10.1161/JAHA.116.004313.

Only half the problem is being addressed: underinsurance is as big a problem as uninsurance.

Int J Health Serv. 2010;40(3):507-23. doi: 10.2190/HS.40.3.g.

How many are underinsured? Trends among U.S. adults, 2003 and 2007.

Health Aff (Millwood). 2008 Jul-Aug;27(4):w298-309. doi: 10.1377/hlthaff.27.4.w298. Epub 2008 Jun 10.

Affordable Care Act reforms could reduce the number of underinsured US adults by 70 percent.

Health Aff (Millwood). 2011 Sep;30(9):1762-71. doi: 10.1377/hlthaff.2011.0335.

引用本文的文献

The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia.

J Manag Care Spec Pharm. 2021 May;27(5):554-564. doi: 10.18553/jmcp.2021.27.5.554.

The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Curr Oncol. 2021 Mar 15;28(2):1216-1248. doi: 10.3390/curroncol28020117.

Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017.

Value Health. 2019 Dec;22(12):1387-1395. doi: 10.1016/j.jval.2019.08.005. Epub 2019 Sep 23.

本文引用的文献

Analyzing the affordable care act: essential health benefits and implications for oncology.

J Oncol Pract. 2013 Mar;9(2):73-7. doi: 10.1200/JOP.2012.000881.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Blood. 2013 May 30;121(22):4439-42. doi: 10.1182/blood-2013-03-490003. Epub 2013 Apr 25.

2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy.

Oncol Nurs Forum. 2013 May 1;40(3):225-33. doi: 10.1188/13.ONF.40-03AP2.

The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.

Oncologist. 2013;18(4):381-90. doi: 10.1634/theoncologist.2012-0279. Epub 2013 Feb 26.

International variability in the reimbursement of cancer drugs by publically funded drug programs.

Curr Oncol. 2012 Jun;19(3):e165-76. doi: 10.3747/co.19.946.

Oral/infusion cancer drug parity begins to raise health plan costs.

Manag Care. 2012 Jan;21(1):7-8.

Persistence with biologic therapies in the Medicare coverage gap.

Am J Manag Care. 2011 Nov;17(11):753-9.

Part D coverage gap and adherence to diabetes medications.

Am J Manag Care. 2010;16(12):911-8.

Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.

Oncologist. 2010;15 Suppl 1:49-57. doi: 10.1634/theoncologist.2010-S1-49.

Increase in oral cancer drugs raises thorny issues for oncology practices.

J Natl Cancer Inst. 2009 Nov 18;101(22):1534-6. doi: 10.1093/jnci/djp421. Epub 2009 Oct 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Oral cancer therapy: policy implications for the uninsured and underinsured populations.

作者信息

Faiman Beth

机构信息

Cleveland Clinic, Cleveland, Ohio.

出版信息

J Adv Pract Oncol. 2013 Sep;4(5):354-60. doi: 10.6004/jadpro.2013.4.5.7.

DOI:10.6004/jadpro.2013.4.5.7

PMID:25032014

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4093446/

Abstract

摘要

相似文献

Oral cancer therapy: policy implications for the uninsured and underinsured populations.

J Adv Pract Oncol. 2013 Sep;4(5):354-60. doi: 10.6004/jadpro.2013.4.5.7.

Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women.

BMC Womens Health. 2018 Oct 3;18(1):162. doi: 10.1186/s12905-018-0656-3.

Antidepressant Target Dose Optimization and Control of Severe Asthma Exacerbations in Uninsured and Underinsured Patients with Anxiety and/or Depression.

Pharmacotherapy. 2020 Apr;40(4):320-330. doi: 10.1002/phar.2374. Epub 2020 Mar 10.

Cost-efficient treatment for uninsured or underinsured patients with hypertension, depression, diabetes mellitus, insomnia, and gastroesophageal reflux.

J Am Acad Nurse Pract. 2008 Mar;20(3):136-43. doi: 10.1111/j.1745-7599.2007.00302.x.

Insured but not protected: how many adults are underinsured?

Health Aff (Millwood). 2005 Jan-Jun;Suppl Web Exclusives:W5-289-W5-302. doi: 10.1377/hlthaff.w5.289.

Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review, Part 1.

Headache. 2018 Apr;58(4):506-511. doi: 10.1111/head.13286. Epub 2018 Mar 8.

Insurance Status Among Adults With Hypertension-The Impact of Underinsurance.

J Am Heart Assoc. 2016 Dec 21;5(12):e004313. doi: 10.1161/JAHA.116.004313.

Only half the problem is being addressed: underinsurance is as big a problem as uninsurance.

Int J Health Serv. 2010;40(3):507-23. doi: 10.2190/HS.40.3.g.

How many are underinsured? Trends among U.S. adults, 2003 and 2007.

Health Aff (Millwood). 2008 Jul-Aug;27(4):w298-309. doi: 10.1377/hlthaff.27.4.w298. Epub 2008 Jun 10.

Affordable Care Act reforms could reduce the number of underinsured US adults by 70 percent.

Health Aff (Millwood). 2011 Sep;30(9):1762-71. doi: 10.1377/hlthaff.2011.0335.

引用本文的文献

The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia.

J Manag Care Spec Pharm. 2021 May;27(5):554-564. doi: 10.18553/jmcp.2021.27.5.554.

The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Curr Oncol. 2021 Mar 15;28(2):1216-1248. doi: 10.3390/curroncol28020117.

Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017.

Value Health. 2019 Dec;22(12):1387-1395. doi: 10.1016/j.jval.2019.08.005. Epub 2019 Sep 23.

本文引用的文献

Analyzing the affordable care act: essential health benefits and implications for oncology.

J Oncol Pract. 2013 Mar;9(2):73-7. doi: 10.1200/JOP.2012.000881.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Blood. 2013 May 30;121(22):4439-42. doi: 10.1182/blood-2013-03-490003. Epub 2013 Apr 25.

Oncol Nurs Forum. 2013 May 1;40(3):225-33. doi: 10.1188/13.ONF.40-03AP2.

The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.

Oncologist. 2013;18(4):381-90. doi: 10.1634/theoncologist.2012-0279. Epub 2013 Feb 26.

International variability in the reimbursement of cancer drugs by publically funded drug programs.

Curr Oncol. 2012 Jun;19(3):e165-76. doi: 10.3747/co.19.946.

Oral/infusion cancer drug parity begins to raise health plan costs.

Manag Care. 2012 Jan;21(1):7-8.

Persistence with biologic therapies in the Medicare coverage gap.

Am J Manag Care. 2011 Nov;17(11):753-9.

Part D coverage gap and adherence to diabetes medications.

Am J Manag Care. 2010;16(12):911-8.

Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.

Oncologist. 2010;15 Suppl 1:49-57. doi: 10.1634/theoncologist.2010-S1-49.

Increase in oral cancer drugs raises thorny issues for oncology practices.

J Natl Cancer Inst. 2009 Nov 18;101(22):1534-6. doi: 10.1093/jnci/djp421. Epub 2009 Oct 30.